학술논문

RESULTS OF TREATMENT WITH BELANTAMAB MAFODOTIN AS COMPASSIONATE USE-EXPANDED ACCESS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA PATIENTS (MMRR)